$PLRX Cashflow Statement | Understand Stock

$PLRX

$0.86 +$0.01 (0.86%) Close

$PLRX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense
Stock-based compensation expense
Gain on sale of property plant and equipment
Non-cash operating lease expense
Other
Amortization (accretion) on short-term investments
Loss on extinguishment of debt
Changes in operating assets and liabilities:
Tax credit receivable
Accounts receivable
Prepaid expenses and other current assets
Other non-current assets
Accounts payable
Accrued liabilities
Operating lease liabilities
Deferred rent and other long-term liabilities

Net cash used in operating activities
Cash flows from investing activities
Purchase of short-term investments
Accretion on short-term investments
Maturity of short-term investments
Purchase of property and equipment
Proceeds from sale of property, plant and equipment
Net cash provided by investing activities

Cash flows from financing activities
Proceeds from sale of common stock in a public offering
Proceeds from issuance of common stock upon completion of private placement
Proceeds from issuance of Series C preferred stock, net of issuance costs
Proceeds from issuances of common stock
Proceeds from issuances of common stock under benefit plans
Payment of offering costs
Payment of debt issuance costs
Payment of debt
Proceeds from term loan, net of issuance costs
Net cash (used in) provided by financing activities

Net (decrease) increase in cash and cash equivalents
Cash, cash equivalents and restricted cash at beginning of period
Supplemental disclosures of noncash investing and financing activities:
Net unrealized (loss) gain on short-term investments
Purchase of property and equipment in accounts payable
Reclassification of restricted stock awards from liabilities to common stock upon vesting
Accretion to redemption value and dividends on redeemable convertible preferred stock
Deferred offering costs in accounts payable and accrued liabilities

Supplemental disclosures of cash flow information related to leases:
Cash paid for operating lease liabilities in operating cash flows
Right-of-use assets obtained in exchange for new operating lease liabilities
Decrease in right-of -use assets and liabilities from lease modifications
Cash, cash equivalents and restricted cash at end of period
Supplemental disclosures of cash flow information:
Cash paid for interest
Reconciliation of cash, cash equivalents, and restricted cash reported in the balance sheets
Cash and cash equivalents
Restricted cash

Comments